Pharmaceuticals

We may look back on new weight-loss drugs as some of the greatest advances in the annals of chronic disease.

The lawyer and his clients have made millions by exposing one Wall Street crime after another. But are they changing the industry?

Absent a concerted global commitment to vaccine equity, the virus will continue to evolve, and humanity may be consigned to a never-ending pandemic.

The race is nearly complete, but distributing the doses will be a breathtaking challenge.

It’s essential to remember that experimental drugs are just that: experiments. Many of them prove to be dangerous and are never approved.

The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthy—and off the hook for good.

An epidemiologist and expert on clinical trials discusses what makes a good trial, why a pandemic is not the time to speed up the drug-approval process, and the most important fixes for our health-care system.

At the Charleston Gazette-Mail, in West Virginia, Eric Eyre’s career has been the stuff of quiet legend. But his work also ties into the deeper, darker narrative of local journalism.